TD Cowen Maintains Buy on HCA Healthcare, Lowers Price Target to $440
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Gary Taylor maintains a Buy rating on HCA Healthcare but lowers the price target from $450 to $440.
October 28, 2024 | 4:05 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
TD Cowen analyst Gary Taylor maintains a Buy rating on HCA Healthcare but lowers the price target from $450 to $440.
The Buy rating suggests continued confidence in HCA's performance, but the lowered price target indicates a slightly less optimistic outlook. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100